Newron Pharmaceuticals
NWRN.SW
#8339
Rank
C$0.26 B
Marketcap
$13.52
Share price
0.61%
Change (1 day)
9.63%
Change (1 year)

EPS for Newron Pharmaceuticals (NWRN.SW)

EPS in 2023: -$1.56

According to Newron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$1.56. In 2023 the company made an earnings per share (EPS) of -$1.56 a decrease over its 2022 EPS that were of -$1.53.

EPS history for Newron Pharmaceuticals from 2005 to 2023

Annual EPS

Year EPS Change
2023-$1.562.03%
2022-$1.5315.39%
2021-$1.33-31.32%
2020-$1.9314.74%
2019-$1.6836.6%
2018-$1.23159.87%
2017-$0.47-67.81%
2016-$1.47-39.24%
2015-$2.42107.61%
2014-$1.1715.8%
2013-$1.01119.91%
2012-$0.46-66.51%
2011-$1.37-71.49%
2010-$4.80-10.83%
2009-$5.3842.06%
2008-$3.7956.53%
2007-$2.42-52.84%
2006-$5.13-188.53%
2005$5.80